NEW YORK (GenomeWeb News) – Genomic Health said today net loss fell by nearly half in the second quarter as product revenues quintupled.
The results caused shares in the company to trade up almost 15 percent, or $1.61, at $12.47 in mid-afternoon today.
Receipts for the three months ended June 30 increased to $8.4 million from $1.2 million year over year, Genomic Health said. Oncotype DX product sales to Medicare and privately insured patients accounted for $7.8 million in revenue.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.